These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16973725)

  • 1. Normal bone density obtained in the absence of insulin receptor expression in bone.
    Irwin R; Lin HV; Motyl KJ; McCabe LR
    Endocrinology; 2006 Dec; 147(12):5760-7. PubMed ID: 16973725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity.
    Coe LM; Lippner D; Perez GI; McCabe LR
    J Cell Biochem; 2011 Sep; 112(9):2403-11. PubMed ID: 21538476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
    Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
    Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
    Duncan ER; Walker SJ; Ezzat VA; Wheatcroft SB; Li JM; Shah AM; Kearney MT
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Botolin S; McCabe LR
    J Cell Physiol; 2006 Dec; 209(3):967-76. PubMed ID: 16972249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I.
    Cao JJ; Kurimoto P; Boudignon B; Rosen C; Lima F; Halloran BP
    J Bone Miner Res; 2007 Aug; 22(8):1271-9. PubMed ID: 17488198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bone marrow microenvironment contributes to type I diabetes induced osteoblast death.
    Coe LM; Irwin R; Lippner D; McCabe LR
    J Cell Physiol; 2011 Feb; 226(2):477-83. PubMed ID: 20677222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor.
    Wheatcroft SB; Shah AM; Li JM; Duncan E; Noronha BT; Crossey PA; Kearney MT
    Diabetes; 2004 Oct; 53(10):2645-52. PubMed ID: 15448096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
    Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
    Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration.
    Kahn MB; Yuldasheva NY; Cubbon RM; Smith J; Rashid ST; Viswambharan H; Imrie H; Abbas A; Rajwani A; Aziz A; Baliga V; Sukumar P; Gage M; Kearney MT; Wheatcroft SB
    Diabetes; 2011 Apr; 60(4):1295-303. PubMed ID: 21317296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats.
    Zhao YF; Zeng DL; Xia LG; Zhang SM; Xu LY; Jiang XQ; Zhang FQ
    Int J Mol Med; 2013 Mar; 31(3):614-20. PubMed ID: 23292283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice.
    Bartell SM; Rayalam S; Ambati S; Gaddam DR; Hartzell DL; Hamrick M; She JX; Della-Fera MA; Baile CA
    J Bone Miner Res; 2011 Aug; 26(8):1710-20. PubMed ID: 21520275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice.
    Shefi-Friedman L; Wertheimer E; Shen S; Bak A; Accili D; Sampson SR
    Am J Physiol Endocrinol Metab; 2001 Jul; 281(1):E16-24. PubMed ID: 11404219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Insulin Receptor Restoration Rescues Vascular Function in Male Insulin Receptor Haploinsufficient Mice.
    Sengupta A; Patel PA; Yuldasheva NY; Mughal RS; Galloway S; Viswambharan H; Walker AMN; Aziz A; Smith J; Ali N; Mercer BN; Imrie H; Sukumar P; Wheatcroft SB; Kearney MT; Cubbon RM
    Endocrinology; 2018 Aug; 159(8):2917-2925. PubMed ID: 29796592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor.
    Vargas SJ; Naprta A; Glaccum M; Lee SK; Kalinowski J; Lorenzo JA
    J Bone Miner Res; 1996 Nov; 11(11):1736-44. PubMed ID: 8915781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
    Botolin S; Faugere MC; Malluche H; Orth M; Meyer R; McCabe LR
    Endocrinology; 2005 Aug; 146(8):3622-31. PubMed ID: 15905321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of reduced c-Kit signaling on bone marrow adiposity.
    Turner RT; Wong CP; Iwaniec UT
    Anat Rec (Hoboken); 2011 Jul; 294(7):1126-34. PubMed ID: 21634019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.